These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 8675656)
1. Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp). Brennan SO; Hammonds B; George PM J Clin Invest; 1995 Dec; 96(6):2854-8. PubMed ID: 8675656 [TBL] [Abstract][Full Text] [Related]
2. A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo. Margaglione M; Vecchione G; Santacroce R; D'Angelo F; Casetta B; Papa ML; Grandone E; Di Minno G Thromb Haemost; 2001 Dec; 86(6):1483-8. PubMed ID: 11776317 [TBL] [Abstract][Full Text] [Related]
3. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis. Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005 [TBL] [Abstract][Full Text] [Related]
4. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions. Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918 [TBL] [Abstract][Full Text] [Related]
5. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain. Stucki B; Zenhäusern R; Biedermann B; Baudo F; Redaelli R; Lämmle B; Furlan M Blood Coagul Fibrinolysis; 1999 Mar; 10(2):93-9. PubMed ID: 10192658 [TBL] [Abstract][Full Text] [Related]
6. Fibrinogen Geneva, a new case of A alpha 16 Arg----Cys dysfibrinogenaemia. Furlan M; Bögli C; Hofer A; Bouvier CA; de Moerloose P Blood Coagul Fibrinolysis; 1990 Jun; 1(2):139-43. PubMed ID: 2130925 [TBL] [Abstract][Full Text] [Related]
7. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions. Soya K; Terasawa F; Okumura N Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100 [TBL] [Abstract][Full Text] [Related]
8. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization. Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560 [TBL] [Abstract][Full Text] [Related]
9. Strategy for recombinant multichain protein synthesis: fibrinogen B beta-chain variants as thrombin substrates. Lord ST; Strickland E; Jayjock E Biochemistry; 1996 Feb; 35(7):2342-8. PubMed ID: 8652575 [TBL] [Abstract][Full Text] [Related]
10. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro). Meyer M; Kutscher G; Stürzebecher J; Riesener G; Lutze G Thromb Res; 2003 Jan; 109(2-3):145-51. PubMed ID: 12706644 [TBL] [Abstract][Full Text] [Related]
11. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen. Rooney MM; Mullin JL; Lord ST Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458 [TBL] [Abstract][Full Text] [Related]
12. Thrombin-bound structures of designed analogs of human fibrinopeptide A determined by quantitative transferred NOE spectroscopy: a new structural basis for thrombin specificity. Ni F; Zhu Y; Scheraga HA J Mol Biol; 1995 Oct; 252(5):656-71. PubMed ID: 7563081 [TBL] [Abstract][Full Text] [Related]
13. Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogen. Seydewitz HH; Gram J; Bruhn HD; Witt I Blood Coagul Fibrinolysis; 1991 Aug; 2(4):501-6. PubMed ID: 1768762 [TBL] [Abstract][Full Text] [Related]
14. Fibrinogen New Britain: characterization of an A alpha Arg 16-->His variant human fibrinogen. Webb CD; Hantgan RR; Byeff PD; Owen J Blood Coagul Fibrinolysis; 1994 Apr; 5(2):233-8. PubMed ID: 8054455 [TBL] [Abstract][Full Text] [Related]
15. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant. Yoshida N; Imaoka S; Hirata H; Matsuda M; Asakura S Thromb Haemost; 1992 Nov; 68(5):534-8. PubMed ID: 1455400 [TBL] [Abstract][Full Text] [Related]
16. Demonstration of heterodimeric fibrinogen molecules partially conjugated with albumin in a novel dysfibrinogen: fibrinogen Mannheim V. Dempfle CE; George PM; Borggrefe M; Neumaier M; Brennan SO Thromb Haemost; 2009 Jul; 102(1):29-34. PubMed ID: 19572064 [TBL] [Abstract][Full Text] [Related]
17. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin. Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717 [TBL] [Abstract][Full Text] [Related]
18. [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys]. Furlan M; Leupin L; Biasiutti FD; Lämmle B Schweiz Med Wochenschr; 1991 Jul; 121(29):1068-71. PubMed ID: 1891701 [TBL] [Abstract][Full Text] [Related]
19. Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aalpha R16C and gamma G165R. Bolliger-Stucki B; Lord ST; Furlan M Blood; 2001 Jul; 98(2):351-7. PubMed ID: 11435303 [TBL] [Abstract][Full Text] [Related]
20. Structural examination of the influence of phosphorylation on the binding of fibrinopeptide A to bovine thrombin. Maurer MC; Peng JL; An SS; Trosset JY; Henschen-Edman A; Scheraga HA Biochemistry; 1998 Apr; 37(17):5888-902. PubMed ID: 9558322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]